COVID-19-Associated Telogen Effluvium After Hospital Discharge: A Prospective Cohort Study

    March 2024 in “ PubMed ”
    Katerina Damevska, Tomica Sotirovski, Bojana Batkoska, Marija Djambazova, Vaska Radeski, Jorde Simonoska, Dimitri Bachevski, Kujtime Rushiti Mehmeti, Tomche Popovski, Ermira Labenishta, Aleksandar Ristovski, Anita Najdova
    TLDR Many severe COVID-19 patients experienced temporary hair loss, but most regrew hair within six months.
    This prospective cohort study assessed the prevalence of telogen effluvium (TE) in 77 patients hospitalized for severe COVID-19. Results showed that 68.8% of patients experienced TE, with 52.8% reporting early onset and 50.9% experiencing moderate hair loss. Complete hair regrowth occurred in 20.7% of patients within three months and in 60.3% within six months, while 7.5% had chronic TE. Female sex, anemia, hypoproteinemia, and severe pneumonia were significantly associated with TE. The study highlights a high prevalence of COVID-19-associated TE, which tends to occur earlier than classic TE and generally has a good prognosis, though chronic cases could have significant health impacts.
    Discuss this study in the Community →